Baker Bros. Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-11,340
| Closed | -$425K | – | 122 |
|
|
2016
Q4 | $425K | Hold |
11,340
| – | – | ﹤0.01% | 122 |
|
|
2016
Q3 | $769K | Hold |
11,340
| – | – | 0.01% | 118 |
|
|
2016
Q2 | $629K | Hold |
11,340
| – | – | 0.01% | 122 |
|
|
2016
Q1 | $712K | Hold |
11,340
| – | – | 0.01% | 122 |
|
|
2015
Q4 | $1.07M | Hold |
11,340
| – | – | 0.01% | 118 |
|
|
2015
Q3 | $911K | Hold |
11,340
| – | – | 0.01% | 120 |
|
|
2015
Q2 | $1.36M | Hold |
11,340
| – | – | 0.01% | 114 |
|
|
2015
Q1 | $1.18M | Sell |
11,340
-260
| -2% | -$27.1K | 0.01% | 118 |
|
|
2014
Q4 | $1.13M | Hold |
11,600
| – | – | 0.01% | 111 |
|
|
2014
Q3 | $906K | Hold |
11,600
| – | – | 0.01% | 98 |
|
|
2014
Q2 | $733K | Hold |
11,600
| – | – | 0.01% | 101 |
|
|
2014
Q1 | $779K | Buy |
+11,600
| New | +$779K | 0.01% | 102 |
|